Fund Research for Morgan Stanley Health Sciences B (HCRBX)

  • Fund Overview

    Fund Inception Date: Oct 30, 1992
    Category: Health
    Overall Risk: Average
    Fund Family: Morgan Stanley
    Return Since Inception: 8.19%
    YTD Return: 16.35%
    Yield (TTM): 0.00%
    Net Assets: 34.41 M
    Morningstar Rating:
    3 of 5

    The investment seeks capital appreciation. The fund normally invests at least 80% of assets in common stocks (including depositary receipts) of health science companies throughout the world. It may invest up to 50% of net assets in foreign securities, including emerging-market securities. The fund may invest the remaining 20% of assets in the common stock of non-health science companies, preferred stock and investment-grade fixed-income securities.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player
    Size
    Average Market Cap $33,127 M
    Market Capitalization Portfolio
    Giant 57.59%
    Large 25.57%
    Medium 13.68%
    Small 3.16%
    Micro 0.00%
    Morningstar Rating as of 10/31/2009
    YTD Returns as of 11/27/2009    		 Style Box Detail calculations do not include the fund's short positions (if any)

  • Fund Performance

    10 year Growth Chart
    Growth of $10,000 from 12/31/1998 to 10/31/2009
    Mouseover the chart to see values for each month.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player

    Total Annualized Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Fund 16.35% 24.64% 0.78% 3.39% 6.09% 8.19%
    +/- Category -1.91% -3.31% 0.74% -0.49% 0.22% —
    +/- S&P 500 TR -7.24% -1.47% 6.25% 2.91% -0.95% —

    Standardized Annual Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Month (as of 10/31/2009) 1.86% -0.79% -2.70% 2.14% 6.09% 8.19%
    Quarter (as of 09/30/2009) 4.28% -14.58% -1.19% 2.18% 6.86% 8.38%
    Fund and Category YTD, 1yr, 3yr and 5yr Returns as of 11/27/2009
    Index YTD,1yr, 3ys and 5yr Returns as of 11/27/2009 10 yr and Since Inception Returns as of 10/31/2009
    Inception Date: 10/30/1992
    Ratings are based on risk-adjusted performance.
    View Total Returns

  • Fund Portfolio Profile

    Sector Breakdown

    Stocks
    Information 0.64%
    Service 98.77%
    Manufacturing 0.00%

    Asset Allocation

    Short Long Net Assets
    Cash — 0.48% 0.48%
    Stocks — 99.53% 99.53%
    Bonds — 0.00% 0.00%
    Other — 0.00% 0.00%
    Foreign Stocks
    (as a % of assets)    		 — 6.93% 6.93%
    Data as of 09/30/2009 Data as of 09/30/2009 View Fund Portfolio

    Top 10 Holdings

    Sector P/E Return as of 10/31/2009 Net Assets
    - JOHNSON & JOHNSON (JNJ) Healthcare 13.73 0.90% 10.82%
    + PFIZER INC (PFE) Healthcare 15.34 -1.02% 10.07%
    + Wyeth (WYE) Healthcare — 36.74% 5.06%
    - ABBOTT LABS (ABT) Healthcare 15.06 -2.59% 4.75%
    + BRISTOL MYERS SQUIBB CO (BMY) Healthcare 13.29 -1.98% 4.50%
    + GILEAD SCIENCES INC (GILD) Healthcare 17.98 -14.35% 4.48%
    - MERCK & CO INC NEW (MRK) Healthcare 9.50 4.64% 4.38%
    + Schering-Plough Corporation (SGP) Healthcare — 66.82% 4.02%
    - MEDTRONIC INC (MDT) Healthcare 20.47 16.45% 3.34%
    + LILLY ELI & CO (LLY) Healthcare — -13.06% 3.17%
    + Increase - Decrease = No change * New since last portfolio
    Top 10 holdings account for the fund's short positions (if any). Net short positions appear shaded.
    P/E as of 11/27/2009
    All other data as of 09/30/2009
    View Fund Portfolio

  • Sales Information

    Sales Charge %

    Initial —
    Deferred 5.00%
    Taken from prospectus dated 07/31/2009
    Expense Ratio (based on net assets) 2.40%
    Taken from annual report dated 07/31/2009

  • Fund Management